Clinical Trial Update: Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) [Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase IIa Venous Thromboembolism (VTE) prevention study in total knee replacement was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: GlaxoSmithKline | Conditions: Venous Thromboembolism | Phase 2 | Status: WITHDRAWN